Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A protumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma
Xiaochao Tan, Lei Shi, Priyam Banerjee, et al.
Journal of Clinical Investigation (2020) Vol. 131, Iss. 1
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Pharmacological reactivation of p53 in the era of precision anticancer medicine
Amos Tuval, Charlotte Strandgren, Angelos Heldin, et al.
Nature Reviews Clinical Oncology (2023) Vol. 21, Iss. 2, pp. 106-120
Closed Access | Times Cited: 41
Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis
Rakhee Bajaj, Amanda N. Warner, Jared J. Fradette, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1484-1484
Open Access | Times Cited: 41
TBC1D23 mediates Golgi-specific LKB1 signaling
Yingfeng Tu, Qin Yang, Min Tang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Adaptation of the Golgi Apparatus in Cancer Cell Invasion and Metastasis
Sarah Bui, Isabel Mejia, Begoña Díaz, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 53
Alterations of Golgi Structural Proteins and Glycosylation Defects in Cancer
Xiaoyan Zhang
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 46
African Swine Fever Virus H240R Protein Inhibits the Production of Type I Interferon through Disrupting the Oligomerization of STING
Guangqiang Ye, Hongyang Liu, Xiaohong Liu, et al.
Journal of Virology (2023) Vol. 97, Iss. 9
Open Access | Times Cited: 20
Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer
Mohamed Haider, Amr Elsherbeny, Valeria Pittalà, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1853-1853
Open Access | Times Cited: 26
Cancer genome and tumor microenvironment: Reciprocal crosstalk shapes lung cancer plasticity
Siavash Mansouri, Daniel Heylmann, Thorsten Stiewe, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 24
Dichotomous roles of ACBD3 in NSCLC growth and metastasis
Xiaochao Tan, Chao‐Liang Wu, Priyam Banerjee, et al.
Oncogene (2025)
Open Access
Dying to Survive—The p53 Paradox
Andrea Lees, Tamas Sessler, Simon S. McDade
Cancers (2021) Vol. 13, Iss. 13, pp. 3257-3257
Open Access | Times Cited: 31
EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer
Xiaochao Tan, Guan-Yu Xiao, Shike Wang, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 7
Open Access | Times Cited: 12
Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
Evangelos Pavlakis, Michelle M. Neumann, Nastasja Merle, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 11
Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer
Xiaochao Tan, Shike Wang, Guan-Yu Xiao, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 12
Open Access | Times Cited: 4
Golgi apparatus targeted therapy in cancer: Are we there yet?
Zheng Yang Lee, Wen Hwei Lee, Jing Sheng Lim, et al.
Life Sciences (2024) Vol. 352, pp. 122868-122868
Closed Access | Times Cited: 4
Golgi’s Role in the Development of Possible New Therapies in Cancer
Dragos-Bogdan Vlad, David-Ioan Dumitrascu, A Dumitraşcu
Cells (2023) Vol. 12, Iss. 11, pp. 1499-1499
Open Access | Times Cited: 9
p53 loss activates prometastatic secretory vesicle biogenesis in the Golgi
Xiaochao Tan, Priyam Banerjee, Lei Shi, et al.
Science Advances (2021) Vol. 7, Iss. 25
Open Access | Times Cited: 22
New insights into the role of the Golgi apparatus in the pathogenesis and therapeutics of human diseases
Wooseon Choi, Shin-Won Kang, Jiyoon Kim
Archives of Pharmacal Research (2022) Vol. 45, Iss. 10, pp. 671-692
Closed Access | Times Cited: 14
Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD
Hang Chen, Wei Shen, Saiqi Ni, et al.
Aging (2021) Vol. 13, Iss. 16, pp. 20684-20697
Open Access | Times Cited: 17
Transcriptional control of a collagen deposition and adhesion process that promotes lung adenocarcinoma growth and metastasis
Xiaochao Tan, Priyam Banerjee, Xin Liu, et al.
JCI Insight (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 15
Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer
Mohamed Haider, Amr El Sherbeny, Valeria Pittalà, et al.
(2022)
Open Access | Times Cited: 9
Prognostic value of p16, p53, and pcna in sarcoma and an evaluation of immune infiltration
Dechao Cai, Xiao Ma, Huihui Guo, et al.
Journal of Orthopaedic Surgery and Research (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Golgi defect as a major contributor to lysosomal dysfunction
Sarah Reem Akaaboune, Yanzhuang Wang
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Targeting the mutant p53 secretome
Kartik Sehgal, David A. Barbie
Journal of Clinical Investigation (2021) Vol. 131, Iss. 1
Open Access | Times Cited: 10
Silencing GOLGA8B inhibits cell invasion and metastasis by suppressing STAT3 signaling pathway in lung squamous cell carcinoma
Zhanzhan Li, Yanyan Li, Na Li, et al.
Clinical Science (2022) Vol. 136, Iss. 11, pp. 895-909
Open Access | Times Cited: 6
A robust CD8+ T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma
Jinteng Feng, Longwen Xu, Shirong Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top